C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/57 (2006.01) A61K 38/48 (2006.01) C12N 9/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2219081
Fragments and an aggregate form of an endothelial cell proliferation inhibitor and methods of use therefor are provided. The endothelial proliferation inhibitor is a protein derived from plasminogen, or more specifically is an angiostatin fragment. The angiostatin fragments generally correspond to krinkle structures occurring within the endothial cell proliferation inhibitor. Angiostatin is also prepared in an aggregate form. The endothelial cell inhibiting activity of the angiostatin fragments and the aggregate angiostatin provide a means for inhibiting angiogenesis of tumors and for treating angiogenic-mediated disease.
On décrit des fragments et une forme agrégée d'un inhibiteur de la prolifération cellulaire endothéliale, ainsi que des procédés d'utilisation de ceux-ci. Cet inhibiteur est constitué d'une protéine dérivée du plasminogène, ou plus spécifiquement d'un fragment d'angiostatine. Les fragments d'angiostatine correspondent généralement à des structures kringle apparaissant dans l'inhibiteur de prolifération cellulaire endothéliale. On prépare également l'angiostatine sous forme agrégée. L'activité inhibitrice de la prolifération des cellules endothéliales desdits fragments et de l'angiostatine agrégée constitue un moyen d'inhibition de l'angiogénèse des tumeurs, et de traitement des maladies induites de façon angiogénique.
Cao Yihai
Folkman M. Judah
Lin Jie
O'reilly Michael S.
Finlayson & Singlehurst
The Children's Medical Center Corporation
LandOfFree
Angiostatin fragments and aggregate angiostatin and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiostatin fragments and aggregate angiostatin and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiostatin fragments and aggregate angiostatin and methods... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1755091